Joshua D. Lee MD, MSc
Associate Professor – Section on Tobacco, Alcohol, and Drug Use
Joshua D. Lee MD, MSc, is an Associate Professor of Population Health and Medicine/General Internal Medicine and Clinical Innovation at the NYU School of Medicine. He is an clinician researcher focused on addiction pharmacotherapies, and is Director of the NYU ABAM Fellowship in Addiction Medicine.
His research models the use of addiction pharmacotherapies in primary care as and criminal justice populations. He has conducted multiple NIH and other clinical trials examining the use of extended-release naltrexone and buprenorphine opioid treatments in outpatient criminal justice involved-adults, in soon-to-be released jail inmates, and in community detox settings. Research on extended-release naltrexone for alcohol treatment has focused on primary care medical management.
Dr. Lee graduated Princeton University (AB), the University of Tennessee School of Medicine (MD), and Cornell University (MSc). He completed a residency and chief residency in Primary Care Internal Medicine at NYU/Bellevue Hospital Center. He is currently an attending physician at Bellevue, in the New York City jails, and private practice.
- Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care
- Extended-Release Naltrexone Opioid Treatment at Jail-to-Community Re-entry